Lidocaine Hydrochloride B. Braun Melsungen (Lidocaine Hydrochloride Monohydrate)

Lidocaine works by blocking voltage‑gated sodium channels on nerve membranes, which prevents the rapid influx of sodium ions needed for depolarisation. This inhibition stops the generation and propagation of nerve impulses, resulting in a reversible loss of sensation in the area where the drug is administered.

The specific dose of lidocaine is determined by the prescribing clinician based on the procedure, patient weight, site of administration and safety considerations. Health‑care professionals calculate the appropriate volume and concentration to achieve effective anesthesia while staying within recommended maximum limits.

Safety data for lidocaine in pregnancy and lactation are limited, and the product does not have a definitive pregnancy category. Clinicians should weigh the potential benefits against any possible risks and use the lowest effective dose if treatment is deemed necessary.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset (1–3 minutes) and intermediate duration (30–120 minutes), making it versatile for many procedures. Compared with shorter‑acting agents like procaine, lidocaine offers faster action and longer analgesia, while its safety profile is well‑established relative to longer‑acting agents such as bupivacaine.

Lidocaine Hydrochloride should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the solution from direct light, moisture and extreme temperature fluctuations to maintain sterility and potency.

The solution is administered by a qualified health‑care professional via epidural catheter, direct infiltration into tissue, or intradermal injection, depending on the clinical indication. Proper aseptic technique and accurate dosing are essential to achieve effective anesthesia and minimise adverse effects.

Serious risks include central nervous system toxicity (seizures, loss of consciousness), cardiovascular toxicity (arrhythmias, severe hypotension, cardiac arrest), methemoglobinemia and severe allergic reactions such as anaphylaxis. Prompt recognition and supportive management are critical if these events occur.

Patients with a known hypersensitivity to amide‑type local anesthetics, severe liver disease, certain cardiac conduction disorders, or those taking medications that markedly increase lidocaine plasma levels should avoid its use unless a specialist determines that benefits outweigh the risks.